Charles River Laboratories | CRL - 销售成本



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 14.75B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


销售成本 更改 日
Agilent USD 836M 9M 2026-06
Align Technology USD 298.76M 4.74M 2026-06
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Cardinal Health USD 61.23B 2.7B 2026-06
Charles River Laboratories USD 655.29M 61.22M 2026-06
Cigna USD 65.13B 2.72B 2026-06
Concord Medical Services Hldg CNY 229.8M 24.9M 2025-12
CVS Health USD 90.35B 5.54B 2026-06
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
Elevance Health USD 38.07B 75M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 389M 19M 2026-06
Incyte USD 104.96M 457K 2026-06
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.22B 141M 2026-06
Laboratory Of America USD 2.7B 97.8M 2026-06
Lakefront Biotherapeutics EUR 9.14M 4.35M 2026-06
Lonza CHF 2.28B 189M 2025-06
McKesson USD 101.7B 9.44B 2026-06
Merck EUR 2.27B 199M 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
Quest Diagnostics USD 2.05B 64M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06
UnitedHealth USD 86.31B 8.41B 2026-03
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 1.16B 430M 2026-06
West Pharmaceutical Services USD 543.1M 5.4M 2026-06